FSPKF OTC
Fisher & Paykel Healthcare Corporation Limited
1W: +1.6%
1M: -2.0%
3M: +15.5%
YTD: +35.0%
1Y: +24.9%
3Y: +114.8%
5Y: +23.9%
$26.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$2.4B
+84.5% ▲
5Y CAGR: +3.9%
Gross Profit
$1.5B
+185.9% ▲
5Y CAGR: +4.4%
Operating Income
$674M
+281.6% ▲
5Y CAGR: -1.4%
Net Income
$473M
+25.4% ▲
5Y CAGR: -2.0%
EPS (Diluted)
$0.81
+26.6% ▲
5Y CAGR: -2.3%
EBITDA
$834M
+27.4% ▲
5Y CAGR: +0.6%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $1.6B | $1.6B | $1.8B | $1.3B | $2.4B |
| YoY Growth | -15.7% | -3.3% | +10.7% | -27.2% | +84.5% |
| Cost of Revenue | $629M | $643M | $698M | $750M | $847M |
| Gross Profit | $1.0B | $946M | $1.1B | $530M | $1.5B |
| Gross Margin | 61.7% | 59.5% | 60.3% | 41.4% | 64.2% |
| R&D Expenses | $154M | $174M | $198M | $227M | $238M |
| SG&A Expenses | $393M | $432M | $493M | $534M | $604M |
| Operating Expenses | $643M | $705M | $805M | $901M | $842M |
| Operating Income | $509M | $335M | $254M | -$371M | $674M |
| Operating Margin | 31.0% | 21.1% | 14.5% | -29.0% | 28.5% |
| Interest Expense | $5M | $7M | $18M | $11M | $10M |
| Income Before Tax | $504M | $328M | $236M | $503M | $638M |
| Tax Expense | $127M | $78M | $103M | $126M | $165M |
| Net Income | $377M | $250M | $133M | $377M | $473M |
| Net Margin | 22.9% | 15.8% | 7.5% | 29.5% | 20.0% |
| EPS (Diluted) | $0.65 | $0.43 | $0.23 | $0.64 | $0.81 |
| EBITDA | $605M | $434M | $368M | $654M | $834M |
| Shares Outstanding | 580M | 582M | 586M | 590M | 591M |